CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares are trading higher Tuesday after the company received U.S. Food and Drug Administration (FDA) Orphan Drug Designation for CER-1236.
What’s Going On With Cero Therapeutics Stock Tuesday?
Where Today's News Shapes Tomorrow
